bromocriptine has been researched along with valproic acid in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (54.17) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Avanzini, G; Caraceni, T; Giovannini, P; Girotti, F | 1 |
| Barba Chacón, A; García Osle, M; García Rojas, JF; Mangas Rojas, A; Zamora Madaria, E | 1 |
| Croughs, RJ; Koppeschaar, HP; McNicol, AM; van't Verlaat, JW | 1 |
| Cookson, JC | 1 |
| Corenblum, B | 1 |
| Kinouchi, T; Shimizu, N; Takeda, F; Yoshida, H | 1 |
| Croughs, RJ; Nortier, JW; Schwarz, F; Thijssen, JH | 1 |
| Croughs, RJ; Koppeschaar, HP; Schwarz, F; Thijssen, JH | 2 |
| Newman, G; Shukla, S; Turner, WJ | 1 |
| Burch, WM | 1 |
| Garg, SK; Kulkarni, SK; Mathur, VS; Shukla, VK | 1 |
| Tegeler, J; Wöller, W | 1 |
| Bergstrand, CG; Nilsson, KO | 1 |
| Crapo, L; Miller, JW | 1 |
| Chik, CL; Cutler, GB; Mercado-Asis, LB; Tracer, HL; Yanovski, JA | 1 |
| Bóné, B; Janszky, J | 1 |
| Bc, M; Chatterjee, SS; Das, S; Kartha, A; Purushothaman, ST; Rajan, V | 1 |
| Kamiyama, T; Mizuno, T; Suzuki, A; Suzuki, M; Takahashi, R | 1 |
7 review(s) available for bromocriptine and valproic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug treatment of bipolar depression and mania.
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bromocriptine; Carbamazepine; Cholinesterase Inhibitors; Clonidine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium; Monoamine Oxidase Inhibitors; Phosphatidylcholines; Tryptophan; Valproic Acid; Verapamil | 1985 |
[Drug and radiotherapy of pituitary tumors].
Topics: Acromegaly; Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Growth Hormone; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Reserpine; Valproic Acid | 1986 |
Cushing's disease. A review.
Topics: Adenoma; Adolescent; Adrenalectomy; Adult; Animals; Bromocriptine; Child; Combined Modality Therapy; Cushing Syndrome; Cyproheptadine; Female; Humans; Hypophysectomy; Male; Microsurgery; Middle Aged; Pituitary Neoplasms; Prognosis; Radiotherapy; Recurrence; Reserpine; Sella Turcica; Valproic Acid | 1985 |
Treatment of Cushing's disease in children.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Child; Cushing Syndrome; Cyproheptadine; Dihydrotestosterone; Female; Humans; Metyrapone; Mitotane; Pituitary Gland; Valproic Acid | 1982 |
The medical treatment of Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Aminoglutethimide; Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dogs; Horses; Humans; Ketoconazole; Metyrapone; Mifepristone; Mitotane; Octreotide; Palliative Care; Pituitary Gland; Radiography; Valproic Acid | 1993 |
[Epilepsy and male sexual dysfunction: etiology, diagnosis and therapy].
Topics: Androgens; Anticonvulsants; Bromocriptine; Carbamazepine; Cognition; Enzyme Induction; Epilepsy; Gonadal Steroid Hormones; Humans; Lamotrigine; Liver; Male; Oxcarbazepine; Phenytoin; Sexual Dysfunctions, Psychological; Testosterone; Triazines; Valproic Acid | 2006 |
1 trial(s) available for bromocriptine and valproic acid
| Article | Year |
|---|---|
Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cyproheptadine; Drug Combinations; Drug Synergism; Female; Humans; Middle Aged; Nelson Syndrome; Time Factors; Valproic Acid | 1997 |
16 other study(ies) available for bromocriptine and valproic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacology of Huntington's chorea. Personal experience.
Topics: Acetates; Adult; Aminobutyrates; Blood Cell Count; Bromocriptine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Physostigmine; Receptors, Dopamine; Valerates; Valproic Acid | 1977 |
[Clinical remission in Cushing's disease through treatment with sodium valproate and bromocriptine].
Topics: Bromocriptine; Chronic Disease; Cushing Syndrome; Cyproheptadine; Drug Therapy, Combination; Female; Humans; Middle Aged; Remission Induction; Time Factors; Valproic Acid | 1991 |
Bromocriptine-responsive Cushing's disease associated with anterior pituitary corticotroph hyperplasia or normal pituitary gland.
Topics: Adolescent; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Humans; Hyperplasia; Male; Pituitary Gland, Anterior; Valproic Acid | 1989 |
The medical treatment of the hypersecreting pituitary gland.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Valproic Acid | 1985 |
No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Male; Middle Aged; Valproic Acid | 1986 |
Response to neurotransmitter modulating drugs in patients with Cushing's disease.
Topics: Adolescent; Adult; Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Hydrocortisone; Male; Middle Aged; Valproic Acid | 1986 |
Bromocriptine-related psychosis and treatment.
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Valproic Acid | 1985 |
GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats.
Topics: Animals; Bromocriptine; Catatonia; Dopamine; Drug Synergism; GABA Antagonists; gamma-Aminobutyric Acid; Injections, Intraventricular; Male; Muscimol; Parasympatholytics; Perphenazine; Piracetam; Rats; Rats, Inbred Strains; Scopolamine; Time Factors; Valproic Acid | 1985 |
[Therapeutic measures in tardive dyskinesia].
Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Humans; Phosphatidylcholines; Schizophrenia; Valproic Acid | 1983 |
Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dexamethasone; Drug Evaluation; Female; Humans; Hydrocortisone; Lypressin; Valproic Acid | 1983 |
Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS).
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Dibenzocycloheptenes; Dopamine Agonists; Drug Overdose; Fluid Therapy; GABA Modulators; Heterocyclic Compounds, 4 or More Rings; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Valproic Acid | 2017 |
Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; BNT162 Vaccine; Bromocriptine; COVID-19; Dantrolene; Humans; Hydrocortisone; Male; Middle Aged; Neuroleptic Malignant Syndrome; Vaccination; Valproic Acid | 2022 |